SEC Form 4 · accession 0001209191-15-068404
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bradbury
Director
Period of report
Aug 26, 2015
Accepted (ET)
Aug 28, 2015 · 1:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Aug 26, 2015 | S | 10,000 | $4.5351 | D | 267,925 | I | BioBrit, LLC |
| Common stockF2 | Aug 27, 2015 | S | 10,000 | $4.99 | D | 257,925 | I | BioBrit, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Price shown is the average price. Price of the individual blocks sold ranged from $4.5 to $4.6 per share.
- F2Price shown is the average price. Price of the individual blocks sold ranged from $4.87 to $5.06 per share.